Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Receiving Influenza Vaccine | Patients who receive an influenza vaccine at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vaccine administration by a pharmacist | Biological | Administration, number and types, of vaccine(s) by a pharmacist |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number and types of vaccines administered | Change from baseline rates at 6 months | |
| Number of unmet vaccination needs identified and met | through study completion, an average of 6 months | |
| Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs | through study completion, an average of 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients receiving an influenza vaccine
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Benjamin M Bluml, BPharm | American Pharmacists Association | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Quality Food Centers #101 | Belfair | Washington | 98528 | United States | ||
| Cheney-Owl Pharmacy |
Not provided
Not provided
Not provided
Not provided
| Unmet vaccination needs identified and met | Behavioral | Identification of unmet vaccination needs and having those needs met |
|
| Vaccination forecast review and patient education | Behavioral | Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs |
|
| Cheney |
| Washington |
| 99004 |
| United States |
| Kirk's Pharmacy | Eatonville | Washington | 98328 | United States |
| Quality Food Centers #851 | Edmonds | Washington | 98020 | United States |
| Lopez Island Pharmacy | Lopez Island | Washington | 98261 | United States |
| Kelley-Ross Pharmacy | Seattle | Washington | 98104 | United States |
| ReliantRx | Spokane | Washington | 99207 | United States |
| Tieton Village Drug | Yakima | Washington | 98902 | United States |
| ID | Term |
|---|---|
| D007251 | Influenza, Human |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D009976 | Orthomyxoviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019859 | Proto-Oncogene Proteins c-met |
| D010353 | Patient Education as Topic |
| ID | Term |
|---|---|
| D020794 | Receptor Protein-Tyrosine Kinases |
| D011505 | Protein-Tyrosine Kinases |
| D011494 | Protein Kinases |
| D017853 | Phosphotransferases (Alcohol Group Acceptor) |
| D010770 | Phosphotransferases |
| D014166 | Transferases |
| D004798 | Enzymes |
| D045762 | Enzymes and Coenzymes |
| D047908 | Intracellular Signaling Peptides and Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D011956 | Receptors, Cell Surface |
| D008565 | Membrane Proteins |
| D017978 | Receptors, Growth Factor |
| D018000 | Receptors, Peptide |
| D011518 | Proto-Oncogene Proteins |
| D015513 | Oncogene Proteins |
| D009363 | Neoplasm Proteins |
| D006266 | Health Education |
| D011314 | Preventive Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided